Combining Phenobarbital and Indomethacin to Improve Early Neonatal Outcomes in the Extremely Low Birth Weight Infant

ABSTRACT

In this retrospective study, we tested the following hypotheses: rates of severe intraventricular hemorrhage (SIVH) and early neonatal survival are similar among extremely low birth weight (ELBW) infants treated with combination prophylaxis of phenobarbital and indomethacin compared with phenobarbital alone or no prophylaxis; and rates of patent ductus arteriosus (PDA) and necrotizing enterocolitis (NEC) are similar among indomethacin-exposed and nonexposed ELBW infants. Data were abstracted on 265 ELBW infants admitted into a level 3 neonatal intensive care unit from 1994 through 2002. Combination prophylaxis neither reduced the odds ratio (OR) of SIVH (OR = 1.53; 95% confidence interval [CI], 0.43 to 1.16) versus phenobarbital (OR = 2.91; 95% CI, 0.91 to 9.27 versus none (OR = 1; 95% CI, reference) nor increased the odds of early neonatal survival (OR = 0.72; 95% CI, 0.17 to 3.09 for combination prophylaxis versus OR = 0.66; 95% CI, 0.16 to 2.67 for phenobarbital versus OR = 1; 95% CI, reference for none). Indomethacin exposure reduced the odds of PDA (OR = 0.35; 95% CI, 0.17 to 0.75) without increasing the risk of NEC (OR = 1.37; 95% CI, 0.60 to 3.12). In conclusion, combination prophylaxis does not improve SIVH and early neonatal survival outcomes. Early exposure to indomethacin offers some benefits without any added risks.

KEYWORDS

Hemorrhage - survival - neonate

REFERENCES

• 1 Krishnamoorthy K S, Shannon D C, DeLong G R, Todres I D, David K R. Neurological sequelae in the survivors of neonatal intraventricular hemorrhage.  Pediatrics. 1979;  64 233-237
• 2 McMenamin J B, Shackelford G D, Volpe J J. Outcome of neonatal intraventricular hemorrhage with periventricular echodense lesions.  Ann Neurol. 1984;  15 285-290
• 3 Williamson W D, Desmond M M, Wilson G S, Murphy M A, Rozelle J, Garcia-Prats J A. Survival of low birth weight infants with intraventricular hemorrhage. Outcome in the preschool years.  Am J Dis Child. 1983;  137 1181-1184
• 4 Ment L R, Duncan C C, Ehrenkranz R A et al.. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants.  J Pediatr. 1985;  107 937-943
• 5 Hanigan W C, Kennedy G, Roemisch F, Anderson R, Cusack T, Powers W. Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates.  J Pediatr. 1988;  112 941-947
• 6 Couser R J, Ferrara T B, Wright G B et al.. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room.  J Pediatr. 1996;  128 631-637
• 7 Bandstra E S, Montalvo B M, Goldberg R N et al.. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants.  Pediatrics. 1988;  82 533-542
• 8 National Institute of Health Consensus Development Conference on the effect of corticosteroids for fetal maturation on perinatal outcomes .Consensus Development Conference Statement. Bethesda, MD; National Institute of Health 1994: pp. 1-21
• 9 Ment L R, Oh W, Ehrenkranz R A, Philip A G, Duncan C C, Makuch R W. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants.  Am J Obstet Gynecol. 1995;  172 795-800
• 10 Bottoms S F, Paul R H, Iams J D et al.. Obstetric determinants of neonatal survival: influence of willingness to perform caesarian delivery on survival of extremely low-birthweight infants. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.  Am J Obstet Gynecol. 1997;  176 960-966
• 11 Donn S M, Roloff D W, Goldstein G W. Prevention of intraventricular hemorrhage in preterm infants by phenobarbitone. A controlled trial.  Lancet. 1981;  2 215-217
• 12 Hope P L, Stewart A L, Thorburn R J, Whitehead M D, Reynolds E OR, Lowe D. Failure of phenobarbitone to prevent intraventricular hemorrhage in small preterm infants.  Lancet. 1982;  1 444-445
• 13 Morgan M EI, Massey R F, Cooke R WI. Does phenobarbitone prevent periventricular hemorrhage in very low birth weight babies? A controlled trial.  Pediatrics. 1982;  70 186-189
• 14 Bedard M P, Shankaran S, Slovis T L, Pantoja A, Dayal B, Poland R L. Effect of prophylactic phenobarbital on intraventricular hemorrhage in high-risk infants.  Pediatrics. 1984;  73 435-439
• 15 Ment L R, Duncan C C, Ehrenkranz R A et al.. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates.  J Pediatr. 1988;  112 948-955
• 16 Ment L R, Oh W, Ehrenkranz R A et al.. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial.  Pediatrics. 1994;  93 543-550
• 17 Bada H S, Green R S, Poucyrous M et al.. Indomethacin reduces the risks of severe intraventricular hemorrhage.  J Pediatr. 1989;  115 631-637
• 18 Yeh T F, Goldbarg H R, Henek T, Thalji A, Pildes R S. Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one-year follow-up.  Am J Dis Child. 1982;  136 803-807
• 19 Schmidt B, Davis P, Moddemann D et al.. Trial of indomethacin prophylaxis in preterms investigators.  N Engl J Med. 2001;  344 1966-1972
• 20 Krueger E, Mellander M, Bratton D, Cotton R. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin.  J Pediatr. 1987;  111 749-754
• 21 Ment L R, Oh W, Ehrenkranz R A et al.. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial.  J Pediatr. 1994;  124 951-955
• 22 Ment L R, Vohr B, Allan W et al.. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial.  Pediatrics. 2000;  105 485-491
• 23 Sulzbacher S, Farwell J R, Temkin N, Lu A S, Hirtz D G. Late cognitive effects of early treatment with phenobarbital.  Clin Pediatr. 1999;  38 387-394
• 24 Lacayo A, Mitra N. Report of a case of phenobarbital-induced dystonia.  Clin Pediatr. 1992;  31 252
• 25 Brent D A, Crumrine P K, Varma R R, Allan M, Allman C. Phenobarbital treatment and major depressive disorders in children with epilepsy.  Pediatrics. 1987;  80 909-917
• 26 Vining E P, Mellitis E D, Dorsen M M et al.. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid.  Pediatrics. 1987;  80 165-174
• 27 Whitelaw A. Postnatal phenobarbitone for the prevention of intraventricular hemorrhage in preterm infants.  Cochrane Database Syst Rev. 2001;  1 CD001691
• 28 Fujii A M, Brown E, Mirochnick M, O'Brien S, Kaufman G. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.  J Perinatol. 2002;  22 535-540
• 29 Grosfeld J L, Chaet M, Molinari F et al.. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arterious treated with indomethacin.  Ann Surg. 1996;  224 350-355
• 30 Horbar J D, Badger G J, Carpenter J H et al.. Trends in mortality and morbidity for very low birth weight infants, 1991-1999.  Pediatrics. 2002;  110 143-151
• 31 Papile L, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.  J Pediatr. 1978;  92 529-534
• 32 Fowlie P W, Davis P G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.  Cochrane Database Syst Rev. 2002;  3 CD0000174
• 33 Ment L R, Stewart W B, Scott D T, Duncan C C. Beagle puppy model of intraventricular hemorrhage: randomized indomethacin prevention trial.  Neurology. 1983;  33 179-184
• 34 Mahony L, Caldwell R L, Girod D A et al.. Indomethacin therapy on the first day of life in infants with very low birth weight.  J Pediatr. 1985;  106 801-805
• 35 Schmidt B, Gillie P, Caco C, Roberts J, Roberts R. Do sick newborn infants benefit from participation in a randomized clinical trial?.  J Pediatr. 1999;  134 151-155
• 36 Silverman W A. Disclosing the “inclusion benefit”.  J Perinatol. 2002;  22 261-262
• 37 Okah F A. The autopsy: experience of a regional neonatal intensive care unit.  Paediatr Perinat Epidemiol. 2002;  16 350-354
• 38 Mellander M, Leheup B, Lindstrom D P et al.. Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin.  J Pediatr. 1984;  105 138-143
• 39 Rennie J M, Doyle J, Cooke R W. Early administration of indomethacin to preterm infants.  Arch Dis Childh. 1986;  61 233-238
• 40 Meidell R, Marinelli P, Pettett G. Perinatal factors associated with early-onset intracranial hemorrhage in premature infants. A prospective study.  Am J Dis Child. 1985;  139 160-163
• 41 Perlman J M, Volpe J J. Intraventricular hemorrhage in extremely small premature infants.  Am J Dis Child. 1986;  140 1122-1124